COPD Endobronchial Treatments (Coil / Valve)

Request a Free Medical Opinion

Please enable JavaScript in your browser to complete this form.

Understanding COPD and Advanced Emphysema

Chronic Obstructive Pulmonary Disease (COPD) is a progressive respiratory disease that causes airflow limitation and chronic breathing difficulties. The condition is usually associated with long-term smoking, environmental exposure, occupational pollutants, chronic airway inflammation, and genetic factors. COPD includes chronic bronchitis and emphysema, both of which may severely affect lung function over time.

In emphysema, the tiny air sacs in the lungs known as alveoli gradually lose their elasticity and become damaged. As a result, air becomes trapped inside the lungs, causing hyperinflation. This trapped air reduces the lungs’ ability to exchange oxygen effectively and forces respiratory muscles to work harder during breathing. Patients with advanced emphysema often experience severe shortness of breath, chronic fatigue, reduced physical activity, and significant decline in quality of life.

While medications, inhalers, pulmonary rehabilitation, oxygen therapy, and smoking cessation remain essential in COPD management, some patients continue experiencing disabling symptoms despite optimal medical treatment. In carefully selected individuals, minimally invasive endobronchial procedures such as coil and valve therapies may provide additional symptom relief and functional improvement.

What are Endobronchial Coil and Valve Treatments?

Endobronchial coil and valve procedures are advanced interventional pulmonology treatments developed for severe emphysema patients with significant lung hyperinflation. These minimally invasive procedures aim to reduce the volume of the most damaged lung areas, allowing healthier lung tissue to function more effectively.

Endobronchial valves are tiny one-way devices inserted into targeted airways using bronchoscopy. These valves allow trapped air and secretions to exit the diseased lung section while preventing new air from entering. Over time, the treated area partially collapses in a controlled manner, reducing hyperinflation and creating more space for healthier parts of the lung to expand.

Endobronchial coils work differently. Flexible nitinol coils are placed into diseased lung tissue through bronchoscopy. Once deployed, the coils return to their original shape and compress the damaged lung tissue mechanically. This helps restore elastic recoil, reduce air trapping, and improve breathing mechanics.

Both procedures are considered alternatives to more invasive surgical lung volume reduction techniques in selected patients.

Which Patients are Candidates for Coil or Valve Therapy?

Careful patient selection is one of the most important factors in successful endobronchial treatment. Not all COPD patients are suitable candidates for these procedures. Coil and valve therapies are generally considered for patients with advanced emphysema who continue experiencing severe respiratory symptoms despite maximal medical therapy.

Before treatment, pulmonologists perform comprehensive evaluations including pulmonary function tests, arterial blood gas analysis, high-resolution CT imaging, exercise testing, and detailed assessment of emphysema distribution. Physicians also evaluate the degree of hyperinflation, airway anatomy, oxygen dependence, and the patient’s overall physical condition.

Valve therapy may be particularly effective in patients with specific emphysema patterns and limited collateral ventilation between lung segments. Coil therapy may be considered in cases where valve placement is less suitable due to lung anatomy or collateral airflow characteristics.

Candidates are usually evaluated by multidisciplinary Chest Diseases and Interventional Pulmonology teams experienced in advanced emphysema treatment planning.

How are Coil and Valve Procedures Performed?

Both procedures are performed using bronchoscopy, which allows physicians to access the lungs through the natural airways without surgical incisions. During the procedure, a thin flexible bronchoscope equipped with a camera is inserted through the mouth or nose under sedation or general anesthesia.

In valve therapy, the physician identifies the diseased lung region and carefully places one-way valves into the corresponding airways. These valves block inhaled air from entering damaged lung sections while still allowing trapped air to escape gradually. Over time, this controlled reduction in lung volume may improve respiratory efficiency.

In coil therapy, specially designed flexible coils are delivered into diseased lung tissue using bronchoscopic guidance. After deployment, the coils compress overinflated lung tissue and help improve lung elasticity and airway stability.

Both procedures are minimally invasive compared to thoracic surgery and generally involve shorter recovery periods. Most patients remain under medical observation after the procedure to monitor respiratory status and detect potential complications early.

Benefits of Endobronchial Lung Volume Reduction

One of the primary goals of endobronchial treatment is reducing lung hyperinflation, which is a major contributor to severe breathlessness in advanced emphysema. By decreasing the volume of damaged lung areas, healthier regions can function more efficiently and respiratory muscles can work with less mechanical strain.

Many patients experience improvement in shortness of breath, exercise tolerance, walking distance, and overall daily activity performance after successful treatment. Some individuals report better sleep quality, reduced fatigue, and improved independence in daily life. In selected patients, oxygen requirements may also decrease.

Compared to surgical lung volume reduction procedures, bronchoscopic treatments generally involve lower procedural trauma, shorter hospitalization, and faster recovery. These techniques may provide valuable treatment alternatives for patients who are not suitable candidates for major thoracic surgery due to age or other medical conditions.

Modern interventional pulmonology continues to expand treatment options for severe COPD patients who previously had limited non-surgical alternatives.

Risks and Complications

Although endobronchial coil and valve procedures are minimally invasive, they still involve certain risks that require careful monitoring. One of the most significant complications is pneumothorax, or collapsed lung, particularly after valve placement. Rapid changes in lung pressure and volume can occasionally cause partial lung collapse during the early recovery period.

Other possible complications include COPD exacerbation, respiratory infection, bleeding, persistent cough, chest discomfort, device migration, mucus plugging, or temporary worsening of respiratory symptoms. Some patients may require additional bronchoscopy procedures for device adjustment or removal.

Comprehensive pre-procedure evaluation and experienced interventional pulmonology teams significantly improve procedural safety and patient outcomes. Careful hospital observation after treatment helps identify complications early and allows prompt intervention when necessary.

Despite these risks, many appropriately selected patients achieve meaningful symptom improvement and better quality of life following endobronchial treatment.

Recovery and Long-Term COPD Management

Recovery after coil or valve placement varies depending on COPD severity, baseline lung function, and the patient’s overall health condition. Some patients notice improvement relatively quickly, while others experience gradual benefits over weeks or months as lung mechanics adapt.

Pulmonary rehabilitation remains extremely important after treatment. Respiratory exercises, physical conditioning, nutritional support, smoking cessation, and medication adherence continue to play essential roles in long-term COPD management even after successful bronchoscopic intervention.

Regular follow-up visits allow pulmonologists to evaluate symptom progression, lung function improvement, oxygen requirements, and possible complications. Imaging studies and pulmonary function testing may be repeated periodically to assess treatment effectiveness.

Endobronchial lung volume reduction represents an important advancement in modern COPD care. For carefully selected emphysema patients, these minimally invasive techniques may significantly improve respiratory comfort, daily function, and overall quality of life without requiring major surgery.

FAQ

What is the main purpose of endobronchial valve treatment?

The main goal is reducing hyperinflation in severely damaged emphysematous lung regions to improve breathing efficiency and lung function.

How do endobronchial coils work?

Coils compress diseased lung tissue mechanically, helping reduce trapped air and improve elastic recoil within the lungs.

Are these procedures permanent?

The effects are intended to be long-term, although patients still require lifelong COPD management and follow-up care.

Can these treatments replace COPD medications?

No. Inhalers, pulmonary rehabilitation, smoking cessation, and medical therapy remain essential even after coil or valve procedures.

Is smoking allowed after the procedure?

No. Continuing smoking can worsen emphysema progression and negatively affect treatment outcomes. Smoking cessation is critical.

Are coil and valve procedures safer than surgery?

They are generally considered less invasive than surgical lung volume reduction and may involve shorter recovery periods for selected patients.

Which department performs COPD endobronchial treatments?

These procedures are performed by the Pulmonology department, particularly specialists trained in Interventional Pulmonology and advanced bronchoscopic procedures.

DOCTORS

MedicalPoint International Hospital Prof. Erdal In Chest Diseases
Prof. Erdal İn, M.D.
Chest Diseases
MedicalPoint Izmir Hospital
MedicalPoint International Hospital Asst. Prof. Huseyin Arpag Chest Diseases
Asst. Prof. Hüseyin Arpağ, M.D.
Chest Diseases
MedicalPoint Batman Hospital
MedicalPoint International Hospital Spec. Adnan Tolga Oz Chest Diseases
Spec. Adnan Tolga Öz, M.D.
Chest Diseases
MedicalPoint Izmir Hospital
DEME CETIN compressed
Spec. Demet Çetin, M.D.
Chest Diseases
MedicalPoint Gaziantep Hospital
spec deniz yazan medicalpoint international hospital
Spec. Deniz Yazan, M.D.
Chest Diseases
MedicalPoint Izmir Hospital